FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4233550107> ?p ?o ?g. }

• W4233550107 endingPage "179" @default.
• W4233550107 startingPage "173" @default.
• W4233550107 abstract "The Tigecycline Evaluation and Surveillance Trial (TEST Program) determined the in vitro activity of tigecycline over a large population of organisms from geographically diverse sites. Tigecycline was compared to amikacin, ampicillin, amoxicillin/clavulanic acid, imipenem, cefepime, ceftazidime, ceftriaxone, levofloxacin, minocycline, piperacillin/tazobactam, linezolid, penicillin, and vancomycin against 3989 commonly encountered clinical Gram-negative and Gram-positive pathogens collected from sites in the United States during 2004. The tigecycline activity was equivalent to imipenem against Enterobacteriaceae. Tigecycline inhibited extended-spectrum β-lactamase and AmpC phenotypes at MIC90 values (minimum inhibitory concentration) of ≤2 μg/mL. In vitro results for tigecycline were similar to other broad-spectrum antimicrobial agents against nonfermenters with MIC90 results of 2 μg/mL against Acinetobacter spp. and >16 μg/mL against Pseudomonas aeruginosa. Tigecycline demonstrated potent activity against Staphylococcus aureus (MIC90, 0.25 μg/mL) and enterococci (MIC90, 0.12 μg/mL) regardless of methicillin or vancomycin susceptibility. Tigecycline MIC values were unaffected by penicillin nonsusceptibility and β-lactamase production among fastidious respiratory pathogens (Streptococcus pneumoniae [MIC90, 0.5 μg/mL] and Haemophilus influenzae [MIC90, 0.25 μg/mL]). Tigecycline offers excellent activity against most of the commonly encountered nosocomial and community-acquired bacterial pathogens." @default.
• W4233550107 created "2022-05-12" @default.
• W4233550107 creator A5025221069 @default.
• W4233550107 creator A5033454548 @default.
• W4233550107 creator A5068063972 @default.
• W4233550107 creator A5074503214 @default.
• W4233550107 creator A5076766154 @default.
• W4233550107 creator A5082800922 @default.
• W4233550107 date "2005-07-01" @default.
• W4233550107 modified "2023-10-14" @default.
• W4233550107 title "In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)" @default.
• W4233550107 cites W1976898407 @default.
• W4233550107 cites W1987419309 @default.
• W4233550107 cites W1993886815 @default.
• W4233550107 cites W2007703916 @default.
• W4233550107 cites W2031303083 @default.
• W4233550107 cites W2034482054 @default.
• W4233550107 cites W2069416660 @default.
• W4233550107 cites W2076728316 @default.
• W4233550107 cites W2080598875 @default.
• W4233550107 cites W2095486650 @default.
• W4233550107 cites W2096228389 @default.
• W4233550107 cites W2099596369 @default.
• W4233550107 cites W2113588525 @default.
• W4233550107 cites W2113664107 @default.
• W4233550107 cites W2120706333 @default.
• W4233550107 cites W2126035312 @default.
• W4233550107 cites W2131088077 @default.
• W4233550107 cites W2139818499 @default.
• W4233550107 cites W2146153077 @default.
• W4233550107 cites W2149057824 @default.
• W4233550107 cites W2152567832 @default.
• W4233550107 cites W2156737450 @default.
• W4233550107 cites W2170206890 @default.
• W4233550107 cites W3140296666 @default.
• W4233550107 doi "https://doi.org/10.1016/j.diagmicrobio.2005.06.004" @default.
• W4233550107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16105561" @default.
• W4233550107 hasPublicationYear "2005" @default.
• W4233550107 type Work @default.
• W4233550107 citedByCount "77" @default.
• W4233550107 countsByYear W42335501072012 @default.
• W4233550107 countsByYear W42335501072013 @default.
• W4233550107 countsByYear W42335501072014 @default.
• W4233550107 countsByYear W42335501072015 @default.
• W4233550107 countsByYear W42335501072016 @default.
• W4233550107 countsByYear W42335501072017 @default.
• W4233550107 countsByYear W42335501072018 @default.
• W4233550107 countsByYear W42335501072019 @default.
• W4233550107 countsByYear W42335501072020 @default.
• W4233550107 countsByYear W42335501072021 @default.
• W4233550107 countsByYear W42335501072022 @default.
• W4233550107 crossrefType "journal-article" @default.
• W4233550107 hasAuthorship W4233550107A5025221069 @default.
• W4233550107 hasAuthorship W4233550107A5033454548 @default.
• W4233550107 hasAuthorship W4233550107A5068063972 @default.
• W4233550107 hasAuthorship W4233550107A5074503214 @default.
• W4233550107 hasAuthorship W4233550107A5076766154 @default.
• W4233550107 hasAuthorship W4233550107A5082800922 @default.
• W4233550107 hasConcept C2777027569 @default.
• W4233550107 hasConcept C2777050379 @default.
• W4233550107 hasConcept C2777637488 @default.
• W4233550107 hasConcept C2778193466 @default.
• W4233550107 hasConcept C2778980435 @default.
• W4233550107 hasConcept C2779489039 @default.
• W4233550107 hasConcept C2779631663 @default.
• W4233550107 hasConcept C2908647359 @default.
• W4233550107 hasConcept C501593827 @default.
• W4233550107 hasConcept C523546767 @default.
• W4233550107 hasConcept C54355233 @default.
• W4233550107 hasConcept C71924100 @default.
• W4233550107 hasConcept C86803240 @default.
• W4233550107 hasConcept C89423630 @default.
• W4233550107 hasConcept C94665300 @default.
• W4233550107 hasConcept C99454951 @default.
• W4233550107 hasConceptScore W4233550107C2777027569 @default.
• W4233550107 hasConceptScore W4233550107C2777050379 @default.
• W4233550107 hasConceptScore W4233550107C2777637488 @default.
• W4233550107 hasConceptScore W4233550107C2778193466 @default.
• W4233550107 hasConceptScore W4233550107C2778980435 @default.
• W4233550107 hasConceptScore W4233550107C2779489039 @default.
• W4233550107 hasConceptScore W4233550107C2779631663 @default.
• W4233550107 hasConceptScore W4233550107C2908647359 @default.
• W4233550107 hasConceptScore W4233550107C501593827 @default.
• W4233550107 hasConceptScore W4233550107C523546767 @default.
• W4233550107 hasConceptScore W4233550107C54355233 @default.
• W4233550107 hasConceptScore W4233550107C71924100 @default.
• W4233550107 hasConceptScore W4233550107C86803240 @default.
• W4233550107 hasConceptScore W4233550107C89423630 @default.
• W4233550107 hasConceptScore W4233550107C94665300 @default.
• W4233550107 hasConceptScore W4233550107C99454951 @default.
• W4233550107 hasIssue "3" @default.
• W4233550107 hasLocation W42335501071 @default.
• W4233550107 hasLocation W42335501072 @default.
• W4233550107 hasOpenAccess W4233550107 @default.
• W4233550107 hasPrimaryLocation W42335501071 @default.
• W4233550107 hasRelatedWork W1996732592 @default.
• W4233550107 hasRelatedWork W2035175436 @default.
• W4233550107 hasRelatedWork W2126082816 @default.

• next